Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination insulin-sulfonylurea therapy.

H E Lebovitz1, R Pasmantier

  • 1Department of Medicine, State University of New York Health Science Center, Brooklyn 11203.

Diabetes Care
|June 1, 1990
PubMed
Summary

Combination sulfonylurea-insulin therapy offers limited benefits for most diabetes mellitus patients. However, a specific subset of obese non-insulin-dependent diabetes mellitus patients may see improved glycemic control and reduced insulin needs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas.

Diabetes, obesity & metabolism·2015
Same author

Treatment of Patients with Obese Type 2 Diabetes with Tantalus-DIAMOND® Gastric Electrical Stimulation: Normal Triglycerides Predict Durable Effects for at Least 3 Years.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2015
Same author

Fasting plasma triglycerides predict the glycaemic response to treatment of type 2 diabetes by gastric electrical stimulation. A novel lipotoxicity paradigm.

Diabetic medicine : a journal of the British Diabetic Association·2013
Same author

New treatments of diabetes: the beta-amylin agonists.

Annales d'endocrinologie·2008
Same author

Diagnosis, classification, and pathogenesis of diabetes mellitus.

The Journal of clinical psychiatry·2002
Same author

Oral therapies for diabetic hyperglycemia.

Endocrinology and metabolism clinics of North America·2001

Area of Science:

  • Endocrinology
  • Pharmacology
  • Metabolic Diseases

Background:

  • Combination therapy of sulfonylureas and insulin for diabetes mellitus has been investigated using diverse methodologies.
  • Existing data present conflicting results, hindering definitive conclusions regarding its efficacy.

Purpose of the Study:

  • To evaluate the clinical utility and effectiveness of combined sulfonylurea-insulin therapy in managing diabetes mellitus.
  • To identify patient subgroups that may benefit from this combination treatment.

Main Methods:

  • Review and synthesis of existing research on insulin-sulfonylurea combination therapy.
  • Analysis of patient characteristics, glycemic control metrics, and insulin dosage in response to the therapy.

Main Results:

  • Insulin-sulfonylurea therapy is generally not clinically beneficial for most patients with insulin-dependent diabetes mellitus.
  • Most non-insulin-dependent diabetes mellitus (NIDDM) patients show minimal improvement with this combination.
  • A specific NIDDM subset (mild-moderate obesity, adequate insulin reserve, poor glycemic control despite high insulin doses) may experience significant glycemic improvement and reduced insulin requirements.

Conclusions:

  • The combination of sulfonylureas and insulin is unlikely to be beneficial for the majority of diabetes mellitus patients.
  • Potential benefits are restricted to a select group of NIDDM patients, suggesting a need for personalized treatment approaches.
  • Mechanisms for improvement in the identified subset include enhanced endogenous insulin secretion and potential extrapancreatic effects of sulfonylureas.

Related Experiment Videos